# Centaurus Therapeutics, Inc. — Form D

Centaurus Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-06-28. The offering totals $7.0M, of which $2.0M was reported sold. Industry: Other.

## Offering

- Filed: 2022-06-28
- Form: D
- Accession: 0001935597-22-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $2.0M
- Remaining: $5.0M
- Investors: 1
- Date of first sale: 2022-06-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-450491

## Issuer

- Name: Centaurus Therapeutics, Inc.
- CIK: 0001935597
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1700 OWENS STREET, SUITE 515, SAN FRANCISCO, CA, 94158
- Phone: 415-606-8129

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Jeremy Blitzer | Director | San Francisco, CA |
| Stephen Halasz | Director | San Francisco, CA |
| Jeremy Blitzer | Executive Officer | San Francisco, CA |
| Stephen Halasz | Executive Officer | San Francisco, CA |

## More

- [CIK 1935597 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1935597&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001935597-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.